Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

As President-elect Donald Trump's transition team vets candidates for key healthcare positions, pharmaceutical industry ...

Hypoglycemia can affect people both with diabetes and without, although it’s more common in people with the condition. Some ...

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

For instance, research has shown that drinking 20 milliliters (roughly 4 teaspoons) of ACV daily with water for eight weeks ...

The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

As countries observe World Diabetes Day today, Thursday, November 14, 2024, the growing impact of the disease in Nigeria, along with the struggles of those affected and healthcare providers, has come ...